Furthermore, Iva has a potential neurosupportive therapeutic value for the treatment of insulted neurons in dementia and could be a candidate for a new medication to relieve cognitive dysfunctions which might be partly attributed to blocking of HCN1 channels. The gene discussed is HCN1; the disease is dementia.